Adam Steensberg

Adam ALR0674

President and Chief Executive Officer


Søborg, Denmark


Adam was appointed to the position of CEO at Zealand Pharma in March 2022 and has 20+ years of experience in both the private and public sectors. Adam has led a significant transformation of Zealand and period of growth for the company. Prior to being appointed CEO, Adam served for several years as Zealand’s Chief Medical Officer and Head of Research & Development and was responsible for the company’s R&D strategy and portfolio of drug candidates. Prior to joining Zealand, Adam led clinical research teams as medical director at Novo Nordisk and worked as a clinician at Rigshospitalet, University of Copenhagen. 

His was also as a medical and scientific advisor in the areas of endocrinology, cardiology, gastroenterology and rheumatology, and has significant experience of leading regulatory strategies. 

Adam is a Board Member at DANISH BIO - DANSK BIOTEK.


Adam is a certified medical doctor and holds a Doctor of Medical Sciences degree (D.M.Sc./ from the University of Copenhagen, Denmark, and an MBA from IMD, Switzerland. Adam has published more than 45 peer-reviewed scientific papers in renowned international journals.

Share profile